Earth Science Tech Inc. (ETST)

[Cheds]

Earth Science Tech, Inc. Launches Earth Science Pharmaceutical & MSN-2 Medical Device Websites, Adds Michel Gauthier M.D. to the Advisory Board, and Reports Over 80% Profit Increase



Hollywood, June 19, 2017 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTCPINK: ETST), an innovative biotech company focused on cannabis CBD-based (industrial hemp), cannabinoid research and development, nutraceuticals, pharmaceuticals, medical devices launches a new pharmaceutical & MSN-2 medical device websites to keep stakeholders updated with new developments, progress, and material events in addition to reporting profit increases of over 80% through the year end of 2016.

ETST is pleased to share that it has finalized and launched the new Earth Science Pharma and MSN-2 Medical Device websites, in order to provide stakeholders with continuous updates on the MSN-2 development and providing educational material on its powerful benefits, which were briefly discussed in the end of March.

To accelerate the closing of the pre-launch process of the MSN-2 medical device, ETST has added Michel Gauthier, M.D. to the advisory board. Dr. Gauthier is a real globe trotter, and will become the medical science liaison for the company’s MSN-2 medical device around the globe. As a medical doctor, he has the ability to prescribe the diagnostic test for the women testing the device, which is mandatory in Canada and the vast majority of states in the USA. He will be able to spread the news of Earth Science Tech’s hard work to prevent sexually transmitted infections (STIs) all around the world.

Dr. Michel Aube, ETST’s CEO and CSO shares, “We are very excited to be completing the pre-launch groundwork that will allow us to offer to women a more private and self-directed technique to get tested for STIs. This product, along with the associated diagnostic tests that will be done in our dedicated laboratories, will be beneficial for all sexually active women aged between 15 and 25 years old. This represents 500 million young women around the world. The biological sample collected by our first medical device is so stable that the product can be used by women far from urban areas without worry for the preservation of the specimen under different temperature conditions. I anticipate a great future for this innovative tool.”

The MSN-2 website will help to introduce the product in different countries while the company builds a brand that will be attractive for young women, their parents and other consumers. The new branding will be complemented by a transactional website.

“I’m excited to share our 2016 year end reported an 80% profit increase solely through ETST’s CBD products. We’re also expecting our revenues to drastically increase due to our many new products, the addition of an enormous amount of new store accounts are being opened weekly, as well as our new subsidiary, Kannabidiol, Inc. which is projected to start out strong based on initial sample feedback. We are still in negotiation stages with many large distributors domestically and internationally that are looking to be finalized soon. 2017 is projected to be an extraordinary year for us and we look to be profiting very soon as an overall company including our R&D Division Cannabis Therapuetics. Our projections don’t include our MSN-2 medical device which had amazing feedback at the 6th annual SeeThroughEquity conference and is scheduled to be launched soon. Thanks to our two new websites, our stakeholders can see the steps we are taking as we progressively work on launching this new unique medical device,” stated Nickolas S. Tabraue, ETST’s President, Director, and COO.

https://www.otcmarkets.com/stock/ETST/news/Earth-Science-Tech--Inc--Launches-Earth-Science-Pharmaceutical--amp--MSN-2-Medical-Device-Websites--Adds-Michel-Gauthier-M-D--to-the-Advisory-Board--and-Reports-Over-80--Profit-Increase?id=162404&b=y


$ETST